Clinical Trial Update: CCR5-blockade in Metastatic Colorectal Cancer

View source ↗

Summary

A clinical trial investigating CCR5 blockade in metastatic colorectal cancer has completed; the provided snippet does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: National Center for Tumor Diseases, Heidelberg | Conditions: Colorectal Cancer, Neoplasm Metastasis | Status: COMPLETED